Enzalutamide Implants (Enolen) in Patients With Prostate Cancer (NCT06257693)
A Phase 1 Study to Establish the Feasibility of Enolen (tm) for the Local Delivery of Enzalutamide in Patients With Prostate Cancer
🩺 Plain-English Summary (8th-Grade Level)
The study is to assess whether the Enolen is safe and delivers anti-androgen medication locally in patients that are planning for radical prostatectomy.
Who can join: Review the eligibility criteria below.
Location: Urology Associates of Central California — Fresno, California
Age range: 21 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (10 Sites)
- Urology Associates of Central California — Fresno, California
- University of California San Francisco Helen Diller Family Comprehensive Cancer Center — San Francisco, California
- Northwestern University — Chicago, Illinois
- Mary Bird Cancer Center — Metairie, Louisiana
- Johns Hopkins University School of Medicine — Baltimore, Maryland
- National Institutes of Health Clinical Center — Bethesda, Maryland
- VA Portland Health Care System — Portland, Oregon
- Atlantic Urology Specialists — Myrtle Beach, South Carolina
- Virginia Commonwealth University — Richmond, Virginia
- Aurora Urology — Milwaukee, Wisconsin
📞 Contact the Study Coordinator
Phone: (847) 644-9818
Email: bonnie.wettersten@alessatherapeutics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Prostate Adenocarcinoma
- Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial — Phoenix, Arizona
- Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer — Houston, Texas
- Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer — Houston, Texas
- Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer — Bethesda, Maryland
- Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer — Houston, Texas
- PSMA PET Imaging of Recurrent Prostate Cancer — Basking Ridge, New Jersey
Explore by condition: All Prostate Adenocarcinoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.